BNTC (Benitec Biopharma) Tariff Resilience Score: 6/10 (As of Jun. 29, 2026)


BNTC Benitec Biopharma Inc BNTC
34 GF Score
Price $12.57
View Full Analysis

What is Benitec Biopharma Tariff Resilience Score?

Benitec Biopharma BNTC +1.78% 34 Tariff Resilience Score is 6 as of Jun. 29, 2026. GuruFocus rates BNTC with a GF Score™ of 34/100. Among 1,375 Biotechnology companies, Benitec Biopharma ranks better than 76% on this metric.

Benitec Biopharma has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Benitec Biopharma has Benitec Biopharma's reliance on international research and development partnerships exposes it to some tariff risks. However, the biotech industry often benefits from exemptions, and the company's focus on intellectual property rather than physical goods mitigates direct tariff impacts.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Benitec Biopharma might have Average Resilient.

Benitec Biopharma  (NAS:BNTC) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Benitec Biopharma Tariff Resilience Score Related Terms

BNTC vs IPSC, FBRX, AUTL: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Benitec Biopharma's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Benitec Biopharma Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benitec Biopharma's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Benitec Biopharma's Tariff Resilience Score falls into.


BNTC
34GF Score
Benitec Biopharma Inc BNTC
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Benitec Biopharma (BNTC) has a Tariff Resilience Score of 6 as of Jun. 29, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Benitec Biopharma ranks #330 out of 1375 companies in the Biotechnology industry, placing it in the top 24%.
Is Benitec Biopharma's Tariff Resilience Score too high?
Benitec Biopharma's current Tariff Resilience Score is 6. The Biotechnology industry median Tariff Resilience Score is 4.00. Benitec Biopharma's value of 6 is 50% above this industry median. Based on the distribution chart, Benitec Biopharma ranks #330 out of 1375 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Benitec Biopharma has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Benitec Biopharma's Tariff Resilience Score compare to IPSC and FBRX?
According to the Biotechnology industry distribution chart, Benitec Biopharma ranks #330 out of 1375 companies for Tariff Resilience Score. This places Benitec Biopharma in the top 24% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Benitec Biopharma's value of 6 is 50% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,375 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Benitec Biopharma's current Tariff Resilience Score of 6 is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Benitec Biopharma's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Benitec Biopharma stock overvalued right now?
Benitec Biopharma (BNTC) has a current Tariff Resilience Score of 6. The current Tariff Resilience Score is 6 and 50% above the Biotechnology industry median of 4.00. Benitec Biopharma's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Benitec Biopharma (BNTC), the current Tariff Resilience Score is 6 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Benitec Biopharma Business Description

Address 3940 Trust Way, Hayward, CA, USA, 94545
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
34GF Score

Get the complete analysis for BNTC

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.57
Price